Adapting to Solid Dosage Development and Manufacturing Needs

Find out more about key trends shaping the solid dosage drug development and manufacturing sector and the advances helping companies to overcome common challenges. Furthermore, gain a greater understanding of the role of CDMOs in solid dosage development and manufacturing and how such services providers are adapting to meet the changing demands of industry.

Register Free: https://www.pharmtech.com/pt_w/adapting-to-solid-dosage

Event Overview:

In this exclusive Drug Digest video interview, Felicity Thomas, Europe/senior editor, Pharmaceutical Technology Group, interviews experts about trends shaping solid dosage drug development and manufacturing. During this episode, Felicity chats with Jan Vertommen from Lonza at CPHI Barcelona about key trends, such as advances to help overcome solubility issues and the increasing importance of sustainability, as well as the role of a CDMO in solid dosage development and manufacturing. Additionally, Dave DiProspero from CRB Group details the progression of oral solid dosage manufacturing and the transformation of continuous processes in the sector.

Key Learning Objectives:

• Trends impacting solid dosage drug development and manufacturing.
• Advances helping with solubility challenges in development.
• The need for greater sustainability and how it is impacting solid dosage development and manufacturing.
• The role of a CDMO in solid dosage development and manufacturing.
• How OSD manufacturing has progressed over recent years.
• The progression of continuous processes in OSD manufacturing.
• Future trends in solid dosage development and manufacturing.
• Key takeaways and impressions from CPHI Barcelona.

Who Should Attend:

• CDMOs
• Formulation scientists
• Manufacturers
• Process development experts
• Small-molecule development experts
• Oral dosage form developers and manufacturers

Speaker:

Jan Vertommen
Vice President, Head of Commercial Development, Small Molecules
Lonza

Dave DiProspero
Senior Fellow—Director of Pharmaceutical Process Technology
CRB Group

Dave DiProspero has 25 years of pharmaceutical engineering experience with a specialty in oral solid dose (OSD) form manufacturing operations/facilities/equipment/technology. His primary expertise is in internationally regulated, CGMP operations with a strong engineering, process, containment, equipment, material handling and facility systems integration background. Dave is experienced in site master planning, conceptual/preliminary/detailed facility design, engineering, procurement, qualification, project management and facility assessments. He is a long-term member of the International Society for Pharmaceutical Engineering and has chaired numerous committees–many related to education. Dave is currently the chair of the Facility of the Year Committee and steering committee advisor of the OSD Community of Practice. He is the steering committee manager for the OSD Baseline Guide Volume 3 revision effort.

Register Free: https://www.pharmtech.com/pt_w/adapting-to-solid-dosage